COVID-19 Diagnostics and the New Variants

This panel discussion covers the new COVID-19 variants, specifically the UK and South African variants. Experts in the field of NGS and RT-PCR assays for COVID-19 discussed the most recent findings on the variants, how they could affect the diagnostic kit performance and how clinical labs and manufacturers are responding to appearance of variants. They also discussed what should be the strategy to ensure efficient detection and tracking of new and known mutations as well as what could be the long-term landscape of virus changes.

Webinar Variant Mutation

Ann-Kristin has a background in molecular biology (M.Sc. Molecular Life Science) and before starting as Product Manager at EUROIMMUN, Ann-Kristin worked for another MDx company in product management and marketing in Germany. Since working for EUROIMMUN in 2020, Ann-Kistin has been responsible for the Product Management (among other MDx products) for our EURORealTime SARS-CoV-2 and related tests.

Webinar Variant Mutation

Prof. Tulio de Oliveira is the director of KRISP. He has received his BSc at the Federal University of Rio Grande do Sul (UFRGS), Brazil and MSc/PhD at the Nelson R Mandela School of Medicine, UKZN, South Africa. He was a Marie Curie Research Fellow at the University of Oxford, U.K. from 2004 to 2006 and a Newton Advanced Fellow at the Wellcome Trust Sanger Institute (WTSI) and at the University of Edinburgh from 2015-2019. In 2015, he became a Professor at UKZN and in 2018 an Associate Professor on Global Health at the University of Washington, Seattle, USA. Prof. de Oliveira has worked for over 20 years with viral outbreaks, including HIV, Hepatitis B and C, Chikungunya, Dengue, SARS-CoV-2, Zika and Yellow Fever Virus. Prof. de Oliveira has more than 150 publications, with many of them in, the top scientific journals, Nature, Science and Lancet.

KRISP boasts state-of-the-art laboratory facilities and scientific expertise and capacity not commonly found in Africa. This places their multidisciplinary team in the ideal position of being able to play a critical role in supporting the public health response to the COVID-19 pandemic. Their scientific activities are receiving extensive media coverage in the national and international media.

Webinar Variant Mutation

Dr. Christine E. Regnell holds a PhD from the University of Oslo in Neuroscience and Molecular Biology, and is based in Oslo, Norway. As part of the Centre for Molecular Biology and Neuroscience at the University of Oslo, she has worked with numerous research laboratories across the USA, Norway, and Denmark, including the NIH National Institute of Aging in Bethesda, Maryland, Center for Healthy Aging at Copenhagen University in Copenhagen, and Department of Clinical and Molecular Medicine at NTNU in Trondheim. Her main focus has been on DNA repair and neurodegeneration in the central nervous system. She has been with PerkinElmer for over 5 years, and has worked in various roles within the Applied Genomics portfolio, including sales and product management. She is currently the Sales Leader for the Life Science and Applied Genomics portfolio in the Nordics.

Recent Posts



Recent Tweets